Canexis Pharma AG
Medical Cannabis - THC and CBD Extracts and Pure APIs
Founded in 2020, Canexis Pharma AG specializes in the research and development of pharmaceutical cannabis products. Its own production facility in Schlattingen, Canton of Thurgau, meets the highest quality and safety standards. The manufacturing and narcotics licenses from Swissmedic allow Canexis to create innovative and safe pharmaceutical products, thereby enhancing the quality of life for patients.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
No Awards
Canexis Pharma AG
Medical Cannabis - THC and CBD Extracts and Pure APIs
Website:
canexis.ch/en/
Headquarter:
Schlattingen
Foundation Date:
February 2020
Technology:
- Biotech